T1	p 72 137	dogs and cats presented as veterinary patients in North America .
T2	p 300 313	dogs and cats
T3	p 364 370	dogs .
T4	p 460 524	dogs and cats showing signs of flea allergy dermatitis ( FAD ) .
T5	p 651 758	Dogs and cats with naturally occurring flea infestations , some of which also had signs associated with FAD
T6	p 845 868	( 220 dogs , 189 cats )
T7	p 1787 1832	dogs and cats diagnosed clinically with FAD .
T8	p 1844 1931	397 dogs free of adult heartworm infection from four heartworm-endemic areas of the USA
T9	p 2234 2255	673 dogs and 347 cats
T10	p 2320 2410	animals included 19 purebred or crossbred Collies ( Bearded , Border , and unspecified ) .
T11	p 2561 2574	dogs and cats
T12	p 2849 2864	dogs and cats .
T13	i 29 39	selamectin
T14	i 248 258	selamectin
T15	i 436 446	selamectin
T16	i 540 550	selamectin
T17	i 795 844	three months of topical treatment with selamectin
T18	i 874 898	positive-control product
T19	i 908 916	fenthion
T20	i 933 943	pyrethrins
T21	i 955 965	Selamectin
T22	i 1277 1295	selamectin-treated
T23	i 1732 1742	Selamectin
T24	i 1988 1998	selamectin
T25	i 2012 2022	ivermectin
T26	i 2034 2044	Selamectin
T27	i 2192 2202	Selamectin
T28	i 2490 2500	selamectin
T29	i 2730 2740	Selamectin
T30	o 6 14	Efficacy
T31	o 19 25	safety
T32	o 225 233	efficacy
T33	o 238 244	safety
T34	o 279 296	flea infestations
T35	o 341 360	heartworm infection
T36	o 1081 1093	Flea burdens
T37	o 1111 1127	flea comb counts
T38	o 1132 1159	clinical evaluations of FAD
T39	o 1257 1273	mean flea counts
T40	o 1348 1364	mean flea counts
T41	o 1511 1527	mean flea counts
T42	o 1602 1618	mean flea counts
T43	o 2056 2081	heartworm prevention rate
T44	o 2425 2449	serious adverse events .
T45	o 2505 2521	highly effective
T46	o 2529 2557	control of flea infestations
T47	o 2676 2729	beneficial in alleviating signs associated with FAD .
T48	o 2769 2816	preventing the development of canine heartworms
T49	o 2825 2829	safe
T50	o 2834 2845	topical use